Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. [electronic resource]
Producer: 20071218Description: 1699-717 p. digitalISSN:- 0270-4137
- Adenocarcinoma -- drug therapy
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Ceramides -- pharmacology
- Down-Regulation
- Enzyme Inhibitors -- pharmacology
- Humans
- Male
- Phosphotransferases (Alcohol Group Acceptor) -- antagonists & inhibitors
- Prostatic Neoplasms -- drug therapy
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Sphingosine -- analogs & derivatives
- Thiazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.